<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hu H</submitter><funding>NCI NIH HHS</funding><funding>NIH</funding><pagination>1298-1315</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9414288</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(11)</volume><pubmed_abstract>Substantial progress has been made in understanding how tumors escape immune surveillance. However, few measures to counteract tumor immune evasion have been developed. Suppression of tumor antigen expression is a common adaptive mechanism that cancers use to evade detection and destruction by the immune system. Epigenetic modifications play a critical role in various aspects of immune invasion, including the regulation of tumor antigen expression. To identify epigenetic regulators of tumor antigen expression, we established a transplantable syngeneic tumor model of immune escape with silenced antigen expression and used this system as a platform for a CRISPR-Cas9 suppressor screen for genes encoding epigenetic modifiers. We found that disruption of the genes encoding either of the chromat</pubmed_abstract><journal>Cancer immunology research</journal><pubmed_title>Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity.</pubmed_title><pmcid>PMC9414288</pmcid><funding_grant_id>RO1CA219670</funding_grant_id><funding_grant_id>RO1CA248896</funding_grant_id><funding_grant_id>R01 CA215471</funding_grant_id><funding_grant_id>R01 CA248896</funding_grant_id><funding_grant_id>R01 CA219670</funding_grant_id><funding_grant_id>RO1CA215471</funding_grant_id><pubmed_authors>Ueberheide B</pubmed_authors><pubmed_authors>Sucker A</pubmed_authors><pubmed_authors>Zeck B</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Schadendorf D</pubmed_authors><pubmed_authors>Deng J</pubmed_authors><pubmed_authors>Osman I</pubmed_authors><pubmed_authors>Wong KK</pubmed_authors><pubmed_authors>Chiriboga LA</pubmed_authors><pubmed_authors>Dowling CM</pubmed_authors><pubmed_authors>Cho H</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Huang HY</pubmed_authors><pubmed_authors>Badri S</pubmed_authors><pubmed_authors>Zappile P</pubmed_authors><pubmed_authors>Tang S</pubmed_authors><pubmed_authors>Dolgalev I</pubmed_authors><pubmed_authors>Chen T</pubmed_authors><pubmed_authors>Velcheti V</pubmed_authors><pubmed_authors>Ranieri M</pubmed_authors><pubmed_authors>Ji H</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Labbe K</pubmed_authors><pubmed_authors>Jin Y</pubmed_authors><pubmed_authors>Poirier JT</pubmed_authors><pubmed_authors>Tsirigos A</pubmed_authors><pubmed_authors>Jour G</pubmed_authors><pubmed_authors>Karatza A</pubmed_authors><pubmed_authors>Schalper KA</pubmed_authors><pubmed_authors>Lopez De Rodas Gregorio M</pubmed_authors><pubmed_authors>Hu H</pubmed_authors><pubmed_authors>Han H</pubmed_authors><pubmed_authors>Khodadadi-Jamayran A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity.</name><description>Substantial progress has been made in understanding how tumors escape immune surveillance. However, few measures to counteract tumor immune evasion have been developed. Suppression of tumor antigen expression is a common adaptive mechanism that cancers use to evade detection and destruction by the immune system. Epigenetic modifications play a critical role in various aspects of immune invasion, including the regulation of tumor antigen expression. To identify epigenetic regulators of tumor antigen expression, we established a transplantable syngeneic tumor model of immune escape with silenced antigen expression and used this system as a platform for a CRISPR-Cas9 suppressor screen for genes encoding epigenetic modifiers. We found that disruption of the genes encoding either of the chromat</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-04T13:08:56.235Z</modification><creation>2025-04-04T13:08:56.235Z</creation></dates><accession>S-EPMC9414288</accession><cross_references><pubmed>34462284</pubmed><doi>10.1158/2326-6066.CIR-21-0543</doi></cross_references></HashMap>